Applications of synthetic biology in medical and pharmaceutical fields

X Yan, X Liu, C Zhao, GQ Chen - Signal transduction and targeted …, 2023 - nature.com
Synthetic biology aims to design or assemble existing bioparts or bio-components for useful
bioproperties. During the past decades, progresses have been made to build delicate …

Insulin resistance and pancreatic β cell failure

M Kasuga - The Journal of clinical investigation, 2006 - Am Soc Clin Investig
It is now well accepted that diabetes mellitus is one of the main threats to human health in
the twenty-first century. The total number of people with diabetes worldwide was estimated …

Disruption of histone methylation in developing sperm impairs offspring health transgenerationally

K Siklenka, S Erkek, M Godmann, R Lambrot… - Science, 2015 - science.org
INTRODUCTION Despite the father transmitting half of the heritable information to the
embryo, the focus of preconception health has been the mother. Paternal effects have been …

Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer

S Eser, N Reiff, M Messer, B Seidler, K Gottschalk… - Cancer cell, 2013 - cell.com
Oncogenic Kras activates a plethora of signaling pathways, but our understanding of critical
Ras effectors is still very limited. We show that cell-autonomous phosphoinositide 3-kinase …

The pathogenesis of diabetes

H Guo, H Wu, Z Li - International journal of molecular sciences, 2023 - mdpi.com
Diabetes is the most common metabolic disorder, with an extremely serious effect on health
systems worldwide. It has become a severe, chronic, non-communicable disease after …

Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes

C Chakraborty, CGP Doss… - Wiley …, 2014 - Wiley Online Library
The prevalence of type‐2 diabetes (T2D) is increasing significantly throughout the globe
since the last decade. This heterogeneous and multifactorial disease, also known as insulin …

mTORC1 signaling: a double-edged sword in diabetic β cells

A Ardestani, B Lupse, Y Kido, G Leibowitz, K Maedler - Cell Metabolism, 2018 - cell.com
The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of metabolic
and nutrient cues that integrates environmental inputs into downstream signaling pathways …

Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles

D Adhikari, W Zheng, Y Shen, N Gorre… - Human molecular …, 2010 - academic.oup.com
To maintain the female reproductive lifespan, the majority of ovarian primordial follicles are
preserved in a quiescent state in order to provide ova for later reproductive life. However, the …

miR-375 targets 3′-phosphoinositide–dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β-cells

A El Ouaamari, N Baroukh, GA Martens, P Lebrun… - Diabetes, 2008 - Am Diabetes Assoc
OBJECTIVE—MicroRNAs are short, noncoding RNAs that regulate gene expression. We
hypothesized that the phosphatidylinositol 3-kinase (PI 3-kinase) cascade known to be …

Targeting pancreatic β cells for diabetes treatment

C Jain, null Ansarullah, S Bilekova, H Lickert - Nature Metabolism, 2022 - nature.com
Insulin is a life-saving drug for patients with type 1 diabetes; however, even today, no
pharmacotherapy can prevent the loss or dysfunction of pancreatic insulin-producing β cells …